Cathepsin K Is Present in Invasive Oral Tongue Squamous Cell Carcinoma In Vivo and In Vitro

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Bitu, Carolina C ^a   Kauppila, Joonas H ^a,c   Bufalino, Andréia ^d   Nurmenniemi, Sini ^a   Teppo, Susanna ^a   Keinänen, Meeri ^a   Vilen, Suvi Tuuli ^a,b   Lehenkari, Petri ^a,c   Nyberg, Pia ^a   Coletta, Ricardo D ^d   Salo, Tuula ^a,b,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; ENZYME LOCALIZATION; EPITHELIUM CELL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MYOMA; ORAL TONGUE SQUAMOUS CELL CARCINOMA; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TONGUE CARCINOMA; TUMOR INVASION; TUMOR MICROENVIRONMENT;

AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATHEPSIN K; CELL LINE, TUMOR; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUCINE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ORGAN CULTURE TECHNIQUES; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TONGUE NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84881340728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070925     Document Type: Article

References (40)

1. Curry TE Jr, Dean DD, Sanders SL, Pedigo NG, Jones PB, (1989) The role of ovarian proteases and their inhibitors in ovulation. Steroids 54: 501-521.
2. Zimmerman S, Sutovsky P, (2009) The sperm proteasome during sperm capacitation and fertilization. J Reprod Immunol 83: 19-25.
3. Erdem NF, Carlson ER, Gerard DA, Ichiki AT, (2007) Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J Oral Maxillofac Surg 65: 1725-1733.
4. Knofler M, (2010) Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 54: 269-280.
5. Georges S, Ruiz Velasco C, Trichet V, Fortun Y, Heymann D, et al. (2009) Proteases and bone remodelling. Cytokine Growth Factor Rev 20: 29-41.
6. Honey K, Rudensky AY, (2003) Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 3: 472-482.
7. Glickman MH, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 82: 373-428.
8. Colbert JD, Matthews SP, Miller G, Watts C, (2009) Diverse regulatory roles for lysosomal proteases in the immune response. Eur J Immunol 39: 2955-2965.
9. Werb Z, Vu TH, Rinkenberger JL, Coussens LM, (1999) Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 107: 11-18.
10. Fan TJ, Han LH, Cong RS, Liang J, (2005) Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 37: 719-727.
11. Troen BR, (2006) The regulation of cathepsin K gene expression. Ann N Y Acad Sci 1068: 165-172.
12. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N, (2008) Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke 39: 2603-2610.
13. Yan X, Takahara M, Xie L, Oda Y, Nakahara T, et al. (2011) Stromal expression of cathepsin K in squamous cell carcinoma. J Eur Acad Dermatol Venereol 25: 362-365.
14. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, et al. (2008) Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res 14: 5357-5367.
15. Runger TM, Quintanilla-Dieck MJ, Bhawan J, (2007) Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol 127: 293-297.
16. Everts V, van der Zee E, Creemers L, Beertsen W, (1996) Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 28: 229-245.
17. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, et al. (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271: 12511-12516.
18. Xie L, Moroi Y, Hayashida S, Tsuji G, Takeuchi S, et al. (2011) Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1alpha. J Dermatol Sci 61: 45-50.
19. Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Runger TM, (2009) Expression and regulation of cathepsin K in skin fibroblasts. Exp Dermatol 18: 596-602.
20. Codriansky KA, Quintanilla-Dieck MJ, Gan S, Keady M, Bhawan J, et al. (2009) Intracellular degradation of elastin by cathepsin K in skin fibroblasts-a possible role in photoaging. Photochem Photobiol 85: 1356-1363.
21. Hou WS, Li Z, Gordon RE, Chan K, Klein MJ, et al. (2001) Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol 159: 2167-2177.
22. Samokhin AO, Wong A, Saftig P, Bromme D, (2008) Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 200: 58-68.
23. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, et al. (1997) The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 57: 5386-5390.
24. Brubaker KD, Vessella RL, True LD, Thomas R, Corey E, (2003) Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res 18: 222-230.
25. Le Gall C, Bellahcene A, Bonnelye E, Gasser JA, Castronovo V, et al. (2007) A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res 67: 9894-9902.
26. Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Runger TM, (2008) Cathepsin K in melanoma invasion. J Invest Dermatol 128: 2281-2288.
27. Lopez-Otin C, Matrisian LM, (2007) Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7: 800-808.
28. van den Brule S, Misson P, Buhling F, Lison D, Huaux F, (2005) Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respir Res 6: 84.
29. Nurmenniemi S, Sinikumpu T, Alahuhta I, Salo S, Sutinen M, et al. (2009) A novel organotypic model mimics the tumor microenvironment. Am J Pathol 175: 1281-1291.
30. Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, et al. (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61: 504-513.
31. Podgorski I, Linebaugh BE, Sloane BF, (2007) Cathepsin K in the bone microenvironment: Link between obesity and prostate cancer? Biochem Soc Trans 35: 701-703.
32. Zhang D, Leung N, Weber E, Saftig P, Bromme D, (2011) The effect of cathepsin K deficiency on airway development and TGF-beta1 degradation. Respir Res 12: 72.
33. McQueney MS, Amegadzie BY, D'Alessio K, Hanning CR, McLaughlin MM, et al. (1997) Autocatalytic activation of human cathepsin K. J Biol Chem. 272: 13955-13960.
34. Novinec M, Lenarcic B. (2013) Cathepsin K: A unique collagenolytic cysteine peptidase. Biol Chem. Biological Chemistry. Biological Chemistry. In press.
35. Lewiecki EM, (2009) Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. IDrugs 12: 799-809.
36. Bone HG, McClung MR, Roux C, Recker RR, Eisman JA, et al. (2010) Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density. J Bone Miner Res 25: 937-947.
37. Suojanen J, Sorsa T, Salo T, (2009) Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro. Oral Dis 15: 170-175.
38. Husheem M, Nyman JK, Vaaraniemi J, Vaananen HK, Hentunen TA, (2005) Characterization of circulating human osteoclast progenitors: Development of in vitro resorption assay. Calcif Tissue Int 76: 222-230.
39. Teppo S, Sundquist E, Vered M, Holappa H, Parkkisenniemi J, et al. (2013) The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. Exp Cell Res 319: 376-389.
40. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, et al. (2008) Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol 39: 1212-1220.